高危急性静脉曲张出血的抢先经颈静脉肝内门体分流术:更新和修订的个体患者数据荟萃分析
该更新和修订的两阶段个体患者数据荟萃分析纳入8项研究共1389例患者(抢先经颈静脉肝内门体分流术342例,药物+内镜1047例),发现抢先经颈静脉肝内门体分流术显著降低总体人群1年死亡率(HR=0.43,95%CI:0.32-0.60,p<0.001),并在Child-Pugh两个亚组中均观察到该效应,敏感性分析证实生存获益,作者推荐抢先经颈静脉肝内门体分流术作为首选治疗。
要点
- 抢先经颈静脉肝内门体分流术显著降低高危肝硬化急性静脉曲张出血患者1年死亡率(HR=0.43)。
- 生存获益在Child-Pugh两个亚组中均观察到,敏感性分析证实该获益。
- 作者推荐抢先经颈静脉肝内门体分流术作为此类患者的首选治疗。
核心结论
- 更新的两阶段个体患者数据荟萃分析证实抢先经颈静脉肝内门体分流术在高危肝硬化急性静脉曲张出血患者中具有显著生存优势。
- 作者据此推荐抢先经颈静脉肝内门体分流术作为这些患者的首选治疗。
研究设计与样本
- 更新和修订的个体患者数据荟萃分析,采用两阶段法,纳入8项研究(4项随机临床试验和4项观察性研究)。
- 共纳入1389例患者(抢先经颈静脉肝内门体分流术342例,药物+内镜1047例)。
- 检索截至2022年9月,纳入前次个体患者数据荟萃分析的所有研究并检索其他可能符合条件的出版物。
- 进行敏感性分析,排除4项观察性研究药物+内镜组中入院后72小时内死亡的患者。
主要发现
- 两阶段个体患者数据荟萃分析显示,抢先经颈静脉肝内门体分流术显著降低总体人群死亡率(HR=0.43,95%CI:0.32-0.60,p<0.001)。
- 该效应在Child-Pugh两个亚组患者中均观察到。
- 敏感性分析证实抢先经颈静脉肝内门体分流术的生存获益。
关键数值与推荐
- 高危患者定义为Child-Pugh B级伴活动性出血和Child-Pugh C级<14分。
- 抢先经颈静脉肝内门体分流术定义为入院72小时内放置经颈静脉肝内门体分流术。
- 主要终点为抢先经颈静脉肝内门体分流术对比药物+内镜对1年生存率的影响。
临床怎么用
- 作者推荐抢先经颈静脉肝内门体分流术作为高危肝硬化急性静脉曲张出血患者的首选治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: A previous individual patient data meta-analysis (IPD-MA) showed that compared with drugs+endoscopy, the placement of transjugular portosystemic shunt within 72 hours of admission (pre-emptive transjugular intrahepatic portosystemic shunt: p-TIPS) increases the survival of high-risk patients (Child-Pugh B+ active bleeding and Child-Pugh C<14 points) with cirrhosis and acute variceal bleeding. However, the previous IPD-MA was not a two-stage meta-analysis, did not consider the potential risk of selection bias of observational studies, and did not include the most recent randomized clinical trial. We performed an updated and revised IPD-MA to reassess the efficacy of p-TIPS, addressing all previous issues. APPROACH AND RESULTS: We included all studies from the previous IPD-MA and searched for other possible eligible publications until September 2022. We performed a two-stage IPD-MA of data from 8 studies (4 randomized clinical trials and 4 observational). In addition, we performed a sensitivity analysis excluding those patients dying up to the first 72 hours after admission in the Drugs+Endoscopy arms of the 4 observational studies. The primary end point was the effects of p-TIPS versus Drugs+Endoscopy on 1-year survival.We identified 1389 patients (342 p-TIPS and 1047 Drugs+Endoscopy). The two-stage IPD-MA showed that p-TIPS significantly reduced the mortality in the overall population (HR=0·43, 95% CI: 0.32-0.60, p <0.001. This effect was observed in both subgroups of patients with Child-Pugh. The sensitivity analysis confirmed the survival benefit of p-TIPS. CONCLUSIONS: The updated two-stage IPD-MA confirms the significant survival advantage of p-TIPS in high-risk patients with cirrhosis and acute variceal bleeding. As a result, we recommend p-TIPS as the preferred first-choice treatment for these patients.
引用
- Nicoară-Farcău O, Han G, Rudler M, et al. Pre-emptive TIPS in high-risk acute variceal bleeding. An updated and revised individual patient data meta-analysis. Hepatology. 2023. PMID: 37782566. doi:10.1097/HEP.0000000000000613
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。